http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2602622-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_49f9482d0ae56f3c77198101cae760a9 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4703 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6872 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
filingDate | 2011-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_928b0019ed297be0e7f1a603175c4e11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b385a981a3724e17982765e8c1bee077 |
publicationDate | 2013-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-2602622-A1 |
titleOfInvention | Prediction of response to platinum-based therapy |
abstract | There is provided a method for determining whether a mammalian subject having a cancer belongs to a first or a second group, wherein subjects of the first group are more responsive to a platinum-based treatment than subjects of the second group, comprising the steps of: na) evaluating an amount of Dachshund homolog 2 (DACH2) present in at least part of a sample earlier obtained from said subject, and determining a sample value corresponding to said amount; nb) comparing the sample value obtained in step a) with a reference value; and, nif said sample value is lower than or equal to said reference value, nc1) concluding that said subject belongs to said first group; and n nif said sample value is higher than said reference value, nc2) concluding that said subject belongs to said second group. Corresponding means and uses are also provided. |
priorityDate | 2011-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 310.